Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@PJC3251 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1738708920326070272.png) @PJC3251 Thomas B

Thomas B posts on X about  the most. They currently have XXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1738708920326070272/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1738708920326070272/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +118,108%

### Mentions: X [#](/creator/twitter::1738708920326070272/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1738708920326070272/c:line/m:posts_active.svg)

- X Week X no change
- X Month X -XX%
- X Months XX -XX%
- X Year XX +7,900%

### Followers: XXX [#](/creator/twitter::1738708920326070272/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1738708920326070272/c:line/m:followers.svg)

- X Week XXX +0.56%
- X Month XXX +7.70%
- X Months XXX +174%

### CreatorRank: undefined [#](/creator/twitter::1738708920326070272/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1738708920326070272/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1738708920326070272/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX%

**Top accounts mentioned or mentioned by**
[@cred54675419c](/creator/undefined) [@rinkukumartanw1](/creator/undefined) [@alphavestcap](/creator/undefined) [@jascanlan](/creator/undefined)
### Top Social Posts [#](/creator/twitter::1738708920326070272/posts)
---
Top posts by engagements in the last XX hours

"Commercialization remains the critical catalyst for NWBOalways has been. While MHRA approval will be a major milestone I dont expect the stock price to skyrocket immediately. My view is that the company may choose to issue the remaining authorized shares bringing the outstanding share count up to around XXX billion. Assuming initial UK access I estimate 5001000 patients in the first year which I believe could support a stock valuation in the range of $XXXX. Beyond that valuation becomes more speculative and will depend heavily on additional milestones: Sawston production ramp-up potential EMA"  
![@PJC3251 Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::1738708920326070272.png) [@PJC3251](/creator/x/PJC3251) on [X](/post/tweet/1948729980583584224) 2025-07-25 13:00:07 UTC XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@PJC3251 Avatar @PJC3251 Thomas B

Thomas B posts on X about the most. They currently have XXX followers and X posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXX -XX%
  • X Months XXXXXX -XX%
  • X Year XXXXXX +118,108%

Mentions: X #

Mentions Line Chart

  • X Week X no change
  • X Month X -XX%
  • X Months XX -XX%
  • X Year XX +7,900%

Followers: XXX #

Followers Line Chart

  • X Week XXX +0.56%
  • X Month XXX +7.70%
  • X Months XXX +174%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXXX%

Top accounts mentioned or mentioned by @cred54675419c @rinkukumartanw1 @alphavestcap @jascanlan

Top Social Posts #


Top posts by engagements in the last XX hours

"Commercialization remains the critical catalyst for NWBOalways has been. While MHRA approval will be a major milestone I dont expect the stock price to skyrocket immediately. My view is that the company may choose to issue the remaining authorized shares bringing the outstanding share count up to around XXX billion. Assuming initial UK access I estimate 5001000 patients in the first year which I believe could support a stock valuation in the range of $XXXX. Beyond that valuation becomes more speculative and will depend heavily on additional milestones: Sawston production ramp-up potential EMA"
@PJC3251 Avatar @PJC3251 on X 2025-07-25 13:00:07 UTC XXX followers, XXX engagements

@PJC3251
/creator/twitter::PJC3251